Fairfield, Bush & Co’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $308K | Hold |
691
| – | – | 0.17% | 88 |
|
|
2025
Q1 | $335K | Sell |
691
-88
| -11% | -$42.7K | 0.21% | 84 |
|
|
2024
Q4 | $314K | Sell |
779
-622
| -44% | -$250K | 0.18% | 86 |
|
|
2024
Q3 | $652K | Sell |
1,401
-445
| -24% | -$207K | 0.39% | 64 |
|
|
2024
Q2 | $865K | Sell |
1,846
-220
| -11% | -$103K | 0.52% | 51 |
|
|
2024
Q1 | $864K | Buy |
2,066
+670
| +48% | +$280K | 0.51% | 51 |
|
|
2023
Q4 | $568K | Buy |
+1,396
| New | +$568K | 0.33% | 65 |
|
|
2023
Q3 | – | Sell |
-16
| Closed | -$5.63K | – | 508 |
|
|
2023
Q2 | $5.63K | Buy |
+16
| New | +$5.63K | ﹤0.01% | 366 |
|
|
2022
Q3 | – | Sell |
-16
| Closed | -$5K | – | 459 |
|
|
2022
Q2 | $5K | Buy |
+16
| New | +$5K | ﹤0.01% | 356 |
|